# Mirum Pharmaceuticals, Inc. – FDA Inspection, Jul 24, 2026

Source: https://www.keypedia.com/records/fda_inspections/mirum-pharmaceuticals-inc/e9d59fb4-c972-4887-b533-d10fdca95bc0
Source feed: FDA_Inspections

> FDA inspection 1328024 of Mirum Pharmaceuticals, Inc., July 24, 2026. 1 citation under 21 CFR part 314. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1328024
- Company Name: Mirum Pharmaceuticals, Inc.
- Inspection Date: 2026-07-24
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: San Francisco District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1259153 - 2024-12-05](https://www.keypedia.com/records/fda_inspections/mirum-pharmaceuticals-inc/6e651f6b-bf5a-442a-a9e3-52671438a5ec)
- FDA Inspection 1220683 - 2023-10-03
- FDA Inspection 1142794 - 2021-05-12

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/scott-n-lim/d5e7745a-d804-48d1-8f3b-a94a8d4aed8a)

Company: https://www.keypedia.com/companies/mirum-pharmaceuticals-inc/9b906e94-ef88-467f-8b15-9f0b02d9e49d

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df
